Multiple sclerosis and pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 23, Issue 6, 2011, Pages 435-439

  Tsui, Alex ^a,b   Lee, Martin A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

breast feeding; management; multiple sclerosis; pregnancy; relapses

Indexed keywords

BETA INTERFERON; GLATIRAMER; HYDROCORTISONE; NATALIZUMAB; PREDNISOLONE;

BREAST FEEDING; DISEASE COURSE; FEMALE; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RELAPSE; REVIEW;

ADULT; BREAST FEEDING; DISEASE PROGRESSION; FEMALE; HUMANS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT;

EID: 81255135981     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32834cef8f     Document Type: Review

References (35)

1. Gilmore W, Weiner LP, Correale J. Effect of oestradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from MS patients and normal control subjects. J Immunol 1997; 158:446-451.
2. Luchetti S, Huitinga I, Swaab DF. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 2011; 191:6-21.
3. Nashold FE, Spach KM, Spanie JA, Hayes CE. Estrogen controls vitamin D3- mediated resistnce to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol 2009; 183:3672-3681.
4. Correale J, Ysrraelit MC, Gaitan MI. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 2010; 185:4948-4958.
5. Confavreux C, Hutchinson M, Hours M, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-291.
6. Vukusic S, Hutchinson M, Hours M, et al. For the pregnancy in multiple sclerosis group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of postpartum relapse. Brain 2004; 127:1353-1360.
7. Koch M, Uyttenboogaart M, Heersema D, et al. Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80:676-678.
8. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118:253-261.
9. D'hooghe MB, Nagls G, Uitdehaag BMJ. Long term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 2010; 81:38-41.
10. Rudick RA, Goelz SE. Beta-interferon for multiple sclerosis. Exp Cell Res 2011; 317:1301-1311.
11. Biogen. Avonex (interferon-1a): product monograph. Biogen; 1998.
12. Salminen HJ, Leggett H, Boggild M. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 2010; 257:2020-2023.
13. Sandberg-Wollheim M, Frank D, Goodwin TM, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005; 65:802-806.
14. Amato MP, Portaccio E, Ghezzi A, et al. Pregnancy and foetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology 2010; 75:1794-1802.
15. Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler 2011; 17:958-963.
16. Khatri B, Barkhof F, Comi G, HArtung HP, et al. Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomized extension of the TRANSFORMS study. Lancet Neurol 2011; 10:520-529.
17. Achiron A,Gabbay U, Gilad R,Hassin-Baer S, et al. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 1998; 50:398-402.
18. Sorensen PS, Wanscher B, Jensen CV, et al. Intravenous immunoglobulin G reducesMRIactivity in relapsing multiple sclerosis.Neurology1998; 50:1273-1281.
19. Beitins IZ, Bayard F, Ances IG, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81:936-945.
20. Homar V, Grosek S, Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn. Neonatology 2008; 94:306-309.
21. Haas J. High dose IVIG in the post partum period for prevention of exacerbation of MS. Mult Scler 2000; 6 (Suppl 2):S18-S20; discussion S33.
22. Achiron A, Kishner I, Dolev M, et al. Effect of intravenous immunoglobulin treatment on pregnancy and post partum-related relapses in multiple sclerosis. J Neurol 2004; 251:1133-1137.
23. Langer-Gould A, Huang SM, Gupta R, et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009; 66:958-963.
24. Airas L, Jalkanen A, Alanen A, et al. Breastfeeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 2010; 75:474-476.
25. De Las Heras V, De Andrés C, Té llez N, Tintoré M, EMPATIE Study Group. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler 2007; 13:981-984.
26. Dwosh E, Guimond C, Sadovnick AD. Reproductive counselling for MS: a rationale. Int MS J 2003; 10:52-59.
27. Zuvich RL, McCauley JL, Pericak-Vance MA, Haines JL. Genetics and pathogenesis of multiple sclerosis. Sem Immunol 2009; 21:328-333.
28. Ramagopalan SV, Link J, Byrnes JK, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73:2107-2111.
29. Ramagopalan SV, Herrera BM, Bell JT, et al. Parental transmission of HLADRB1* 15 in multiple sclerosis. Hum Genet 2008; 122:661-663.
30. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1* 1501 is regulated by vitamin D. PLoS Genet 2009; 5:e1000369.
31. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenetics in multiple sclerosis susceptibility: difference in trans- generational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009; 18:261-266.
32. Chao MJ, Ramagopalan SV, Herrara BM, et al. MHC transmission: insight into gender bias in MS susceptibility. Neurology 2011; 71:242-246.
33. Finkelsztegn A, Brooks JBB, Paschoal FM Jr, Gragosa YD. What can we really tell women with multiple sclerosis regarding their pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011; 790-797.
34. Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol 2008; 255:623-627.
35. Lee M, O'Brien P. Multiple sclerosis and pregnancy. J Neurol Neurosurg Psychiatry 2006; 79:1308-1311.